Vanda approves 2023 bonuses, 2024 salaries, and RSU grants for NEOs

Vanda Pharmaceuticals Inc.

CEO Polymeropoulos receives $983K bonus for 2023, 450,000 RSUs vesting over 4 years.
2024 base salaries: CEO $933K, CFO Moran $541K, others $541-560K.
2024 target bonuses: 80% CEO, 45% for other NEOs.
RSU grants total 857,700 shares across five executives.
Compensation committee reviewed Willis Towers Watson peer group analysis.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.